What's new

Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 12, Status: Authorised

Mar 26, 2025 - 16:49
 0
Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Nissan Leaf Is Getting A Glow Up So Impressive It Couldn't Wait To Show Us

Next Article

Elite Biglaw Firm Will No Longer Participate In Law School On-Campus Interview P...

Related Posts

Herbal medicinal product: Tribuli terrestris herba, Tribulus terrestris L., D: Draft under discussion

Herbal medicinal product: Tribuli terrestris herba, Tri...

Feb 27, 2025  0

First topical gene therapy treatment for dystrophic epidermolysis bullosa

First topical gene therapy treatment for dystrophic epi...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation: 07/12/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0